Stockreport

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Company Announcement Net sales of DARZALEX® in the third quarter of 2025 totaled USD 3,672 millionGenmab receives royalties on worldwide net sales from Johnson & Johnso [Read more]